Effect of Denileukin Diftitox in T-Regulatory Cells in CTCL Patients

Trial Profile

Effect of Denileukin Diftitox in T-Regulatory Cells in CTCL Patients

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 24 Mar 2015

At a glance

  • Drugs Denileukin diftitox (Primary)
  • Indications Cutaneous T cell lymphoma
  • Focus Pharmacodynamics
  • Most Recent Events

    • 04 Jun 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top